Creative Planning Ovid Therapeutics Inc. Transaction History

Creative Planning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.13 - $3.73 $46,737 - $55,696	-14,932 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$3.31 - $4.04 $331 - $404	-100 Reduced 0.67%	14,932 $50,000
Q2 2021 Aug 04, 2021	SELL	$3.3 - $4.49 $165 - $224	-50 Reduced 0.33%	15,032 $59,000
Q1 2021 Apr 30, 2021	BUY	$2.42 - $4.47 $242 - $447	100 Added 0.67%	15,082 $61,000
Q3 2020 Nov 05, 2020	SELL	$5.39 - $8.24 $12,127 - $18,540	-2,250 Reduced 13.06%	14,982 $86,000

Q2 2020 Jul 23, 2020	BUY	$2.67 - $7.91 $4,539 - $13,447	1,700 Added 10.95%	17,232 $127,000
Q4 2019 Jan 30, 2020	BUY	$2.08 - $5.06 $1,248 - $3,035	600 Added 4.02%	15,532 $64,000
Q1 2018 Apr 18, 2018	BUY	$6.53 - $9.82 $97,505 - $146,632	14,932 New	14,932 $106,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.